US Approves Drug for Food Allergies in Asthma

A medicine that is currently used to treat asthma has been licensed by the US Food and medicine Administration to treat food allergies in humans. The US Food and Drug Administration (FDA) authorized Xolair for a new purpose on February 16. The first drug that the FDA has approved to lessen allergic reactions brought on by food allergies is called Xolair. Omalizumab is sold under the brand name Xolair, which is also its commercial name. A common concern among allergy sufferers and their families is coming into contact with substances that trigger allergic reactions. They could steer clear of dining establishments. Additionally, they might stay away from social settings where they could come into contact with allergens.

 

The head of the pediatric allergy department at the Johns Hopkins Children’s Center is Dr. Robert Wood. The FDA’s conclusion was supported by Wood’s research. The allergy study was also financed by the National Institutes of Health. The study included 128 participants who were allergic to peanuts and/or at least two other foods. It was discovered that roughly 600 milligrams of peanut protein could be consumed by 68% of those who received Xolair injections without experiencing any major side effects. This figure contrasts with the mere 6% of those who were administered an inert substance in lieu of the medication. The study’s findings held true for other allergens, or foods like tree nuts, milk, eggs, and wheat that frequently trigger reactions.

 

Food allergy patients as young as one year old might receive injections of the medication every two to four weeks. Their weight and how their body reacts to allergies will determine this. Xolair users need to keep avoiding items that trigger allergic responses. Frequently, these items include eggs, milk products, peanuts, cashews, hazelnuts, and walnuts. On the other hand, the drug seems to allow exposure to greater concentrations of foods that trigger allergies without having a significant effect. Despite not having an official approval, doctors have been using the medication to treat food allergies up until now, according to Dr. Ruchi Gupta. “Off-label” refers to this type of second use for a medication.

Be the first to comment

Leave a Reply

Your email address will not be published.


*